Neurology Minute

American Academy of Neurology
undefined
Aug 7, 2023 • 3min

Sports, Exercise, and Seizure Control - Part 1

In part 1 of a 2-part series, Dr. Halley Alexander explores the potential benefits and risks involved for individuals with epilepsy who desire to actively engage in sports or exercise activities.
undefined
Aug 4, 2023 • 2min

A Round Table Update Discussion on FND: Diagnosis of FND and New Phenotypes

Dr. David Perez discusses the diagnosis of FND and new phenotypes. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
undefined
Aug 3, 2023 • 4min

AAN President Elect Rost to Testify on New Alzheimer's Treatments

Dr. Natalia Rost discusses her testimony to Congress on New Alzheimer's Treatments. Show references: This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
undefined
Aug 2, 2023 • 3min

When Myoclonus is Reversible

Dr. Kathryn Zuchowski discusses her NeuroByte, "When Myoclonus Is Reversible". Show references: https://learning.aan.com/diweb/catalog/item?id=11546015 This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
undefined
Aug 1, 2023 • 5min

2024 Medicare Physician Fee Schedule Proposed Rule

Matt Kershner, Director, of Regulatory Affairs & Policy, at the American Academy of Neurology, discusses the 2024 Medicare Physician Fee Schedule Proposed Rule. Show references: https://www.aan.com/advocacy/capitol-hill-report This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
undefined
Jul 31, 2023 • 3min

Pediatric Epilepsy Surgery

Dr. Adam Hartman discusses pediatric epilepsy surgery. Show references: https://www.thelancet.com/pdfs/journals/lanchi/PIIS2352-4642(23)00082-2.pdf https://pubmed.ncbi.nlm.nih.gov/37212692/ This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
undefined
Jul 28, 2023 • 2min

Elamipretide for Mytochondrial Myopathy

Dr. Amel Karaa discusses the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies. Show references: https://n.neurology.org/content/101/3/e238
undefined
Jul 27, 2023 • 1min

Sarepta Announces FDA Approval of ELEVIDYS

Dr. Hoda Abdel-Hamid discusses the recent FDA approval for the first-ever gene therapy for Duchenne muscular dystrophy.
undefined
Jul 26, 2023 • 4min

Anti-Seizure Medication

Dr. Irfan Sheikh sheds light on the usage of anti-seizure medications within the inpatient setting.
undefined
Jul 25, 2023 • 2min

Cognitive Decline Following Heart Attack

Dr. Rae Bacharach discusses the Neurology Today article, "Cognitive Decline Appears to Speed Up in the Years Following a Heart Attack". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/07060/cognitive_decline_appears_to_speed_up_in_the_years.8.aspx

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app